Developer docs
API playgroundTry for free, no card

Search company profiles

Raremark

Full company profile

uuid002i7cq

Namestring
Raremark
Legal namestring
Health Union, LLC
Websiteurl
raremark.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

RareDisease.net is a web-based patient community and health information platform that serves individuals diagnosed with or suspecting rare diseases, along with their caregivers and families. Its surface combines a searchable database of more than 5,000 rare diseases with expert-authored editorial articles, peer discussion forums, first-person patient stories, and curated condition-specific topic collections. The platform is organized around rare-disease conditions and adjacent themes such as diagnosis, caregiving, mental health, and clinical trial navigation, and is accessible globally without geographic restrictions via the public website.

Underlying the platform is a content-first publishing architecture: SEO-structured condition pages serve as the primary top-of-funnel acquisition surface, while forums, stories, and email subscriptions drive mid- and post-engagement retention. Distribution relies on organic search, content marketing, social media (Facebook, Instagram, LinkedIn), and newsletter capture, with no sales-mediated onboarding. The product is free to end users, requiring only account registration for community participation.

The business operates as a community brand within Health Union, LLC's Social Health Network, drawing on shared editorial resources and cross-community promotion across the parent's portfolio of more than 70 condition-specific communities. Revenue is generated through advertising and sponsorship partnerships with healthcare and pharmaceutical companies targeting rare disease audiences. The company is privately held, with no evidence of independent external funding rounds, public listing, or standalone revenue disclosure in the available source data.

Note on identity: while the named firmographic entity references a London-based company founded in 2015, the disclosed product, legal entity, GTM, technology, and partnership evidence all map to the US-based RareDisease.net property under Health Union, LLC, and this description is grounded in that evidence.

Short descriptiontext

RareDisease.net is a web-based patient community and health information platform serving rare disease patients and caregivers, offering a database of 5,000+ conditions, peer forums, patient stories, and curated health resources under Health Union, LLC.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
rare disease information, patient community platform, online health forums, medical content publishing, caregiver support resources
Industry3 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLACAHAH
Patient Registries & Chronic Disease Registry Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
SECONDARYHLAJAJAE
Disease Registries (Cancer, Immunization, Rare Disease, etc.)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
NAICS code3 codes
  • Individual and Family Services6241
  • Other Individual and Family Services624190
  • Social Assistance624
SIC code2 codes
  • Services-Health Services8000
  • Services-Social Services8300
Product category
Online Health Community
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Advertising and Sponsorship
TypeAdvertising
Description

The platform generates revenue through targeted advertising and sponsored content partnerships with healthcare and pharmaceutical companies seeking to reach rare disease patient audiences.

raredisease.net
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Raremark operates RareDisease.net, a free online health community and information platform serving rare disease patients, caregivers, and families. The platform combines a searchable database of more than 5,000 rare diseases with editorial health articles, peer community forums, patient-authored stories, and curated topic collections covering diagnosis, treatment, daily living, mental health, caregiving, and clinical trial navigation. Revenue is generated through targeted advertising and sponsored content partnerships with healthcare and pharmaceutical companies seeking access to rare disease audiences.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

RareDisease.net is a single, unified online health community platform that serves patients, caregivers, and families affected by rare diseases. The core product combines health information, peer community forums, and a condition database. The platform is operated by Health Union, a company that maintains a network of condition-specific online health communities.

Product and service1 record
1RareDisease.net
CategoryOnline Health Community
Description

A free online health community and information platform for rare disease patients, caregivers, and families. Provides a searchable database of more than 5,000 rare diseases, editorial health articles on diagnosis, treatment, daily living, mental health, caregiving and clinical trials, peer discussion forums, first-person patient stories, curated topic collections, and a community poll for clinical trial barriers. Users access the platform directly through the public website without any sales interaction.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Rare Disease.net is a Health Union community, operating as part of Health Union's portfolio of condition-specific online health communities. Health Union reaches millions of people through its Social Health Network and has developed over 70 condition-specific communities across virtually all health conditions. Rare Disease.net benefits from Health Union's infrastructure, editorial resources, and cross-community promotional opportunities.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Network connecting patient leaders across conditions, including rare diseases, monetized through pharma insights and influencer programs. Operates within a category that overlaps Health Union and WEGO Health's adjacent patient-leader business.

2Orphanet
TypeEmerging player
Description

European rare disease knowledge base offering a comprehensive inventory of rare diseases and expert resources. Closely comparable to RareDisease.net's 5,000+ rare disease database, though supported publicly rather than through advertising.

3MyHealthTeams
TypeDirect peer
Description

Operates condition-specific social networks for people with chronic health conditions, monetizing through pharma sponsorship and advertising. Closely matches RareDisease.net's model of free, ad-supported rare/chronic-condition communities combined with editorial content.

TypeEmerging player
Description

US rare disease umbrella nonprofit providing patient education, advocacy, and community resources. Overlaps with RareDisease.net's mission of rare-disease information and support, though operates in nonprofit model.

TypeDirect peer
Description

Online patient community platform connecting patients and caregivers across thousands of conditions, with pharma and biotech sponsorship as a core revenue stream. Directly comparable in audience and monetization model to RareDisease.net.

TypeDirect peer
Description

Mobile patient community and care-management platform supporting cancer and other conditions including rare diseases, monetizing through pharma partnerships. Overlaps with RareDisease.net's patient community and sponsor-supported model.

TypeBroad incumbent
Description

Major consumer health information publisher with extensive condition content. Comparable as a broad incumbent in health content and condition SEO, but does not focus on rare disease peer communities.

TypeDirect peer
Description

Patient network that combines disease communities, shared health data, and patient-reported outcomes, with a heavy focus on rare conditions. Comparable as a peer community and condition-data platform serving pharma and research partners.

9Smart Patients
TypeEmerging player
Description

Online community for patients and caregivers to share learnings about cancer and rare diseases. Directly comparable as a small, niche patient community platform with sponsor-friendly engagement.

10WebMD
TypeBroad incumbent
Description

Largest US consumer health information and advertising platform. Competes for the same pharma advertising and sponsorship dollars as RareDisease.net but covers all conditions rather than specializing in rare diseases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Raremark

Online Health Communityraremark.com

RareDisease.net is a web-based patient community and health information platform serving rare disease patients and caregivers, offering a database of 5,000+ conditions, peer forums, patient stories, and curated health resources under Health Union, LLC.

What Raremark does

RareDisease.net is a web-based patient community and health information platform that serves individuals diagnosed with or suspecting rare diseases, along with their caregivers and families. Its surface combines a searchable database of more than 5,000 rare diseases with expert-authored editorial articles, peer discussion forums, first-person patient stories, and curated condition-specific topic collections. The platform is organized around rare-disease conditions and adjacent themes such as diagnosis, caregiving, mental health, and clinical trial navigation, and is accessible globally without geographic restrictions via the public website.

Underlying the platform is a content-first publishing architecture: SEO-structured condition pages serve as the primary top-of-funnel acquisition surface, while forums, stories, and email subscriptions drive mid- and post-engagement retention. Distribution relies on organic search, content marketing, social media (Facebook, Instagram, LinkedIn), and newsletter capture, with no sales-mediated onboarding. The product is free to end users, requiring only account registration for community participation.

The business operates as a community brand within Health Union, LLC's Social Health Network, drawing on shared editorial resources and cross-community promotion across the parent's portfolio of more than 70 condition-specific communities. Revenue is generated through advertising and sponsorship partnerships with healthcare and pharmaceutical companies targeting rare disease audiences. The company is privately held, with no evidence of independent external funding rounds, public listing, or standalone revenue disclosure in the available source data.

Note on identity: while the named firmographic entity references a London-based company founded in 2015, the disclosed product, legal entity, GTM, technology, and partnership evidence all map to the US-based RareDisease.net property under Health Union, LLC, and this description is grounded in that evidence.

Raremark firmographics

Firmographics
Name
Raremark
Legal name
Health Union, LLC
Website
https://raremark.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
RareDisease.net is a web-based patient community and health information platform serving rare disease patients and caregivers, offering a database of 5,000+ conditions, peer forums, patient stories, and curated health resources under Health Union, LLC.
Ownership category
akta.pro rank

Raremark industry classification

Industry
Product category
Online Health Community
NAICS
Individual and Family Services (6241), Other Individual and Family Services (624190), Social Assistance (624)
SIC
Services-Health Services (8000), Services-Social Services (8300)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLACAHAH
Patient Registries & Chronic Disease Registry Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
SECONDARYHLAJAJAE
Disease Registries (Cancer, Immunization, Rare Disease, etc.)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics

Keywords

  • Rare disease information
  • Patient community platform
  • Online health forums
  • Medical content publishing
  • Caregiver support resources

Where Raremark is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Raremark business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Advertising and Sponsorship: The platform generates revenue through targeted advertising and sponsored content partnerships with healthcare and pharmaceutical companies seeking to reach rare disease patient audiences.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Raremark product offering

Product offering

Core offering

Raremark operates RareDisease.net, a free online health community and information platform serving rare disease patients, caregivers, and families. The platform combines a searchable database of more than 5,000 rare diseases with editorial health articles, peer community forums, patient-authored stories, and curated topic collections covering diagnosis, treatment, daily living, mental health, caregiving, and clinical trial navigation. Revenue is generated through targeted advertising and sponsored content partnerships with healthcare and pharmaceutical companies seeking access to rare disease audiences.

Product overview

RareDisease.net is a single, unified online health community platform that serves patients, caregivers, and families affected by rare diseases. The core product combines health information, peer community forums, and a condition database. The platform is operated by Health Union, a company that maintains a network of condition-specific online health communities.

Differentiator

Problem solved

Functional benefit

Products and services

  • RareDisease.net A free online health community and information platform for rare disease patients, caregivers, and families. Provides a searchable database of more than 5,000 rare diseases, editorial health articles on diagnosis, treatment, daily living, mental health, caregiving and clinical trials, peer discussion forums, first-person patient stories, curated topic collections, and a community poll for clinical trial barriers. Users access the platform directly through the public website without any sales interaction.

Companies that use Raremark

Customer profile

Segments2 records

Ideal customer profiles2 records

Raremark technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Raremark partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Health UnioncoreOthersRare Disease.net is a Health Union community, operating as part of Health Union's portfolio of condition-specific online health communities. Health Union reaches millions of people through its Social Health Network and has developed over 70 condition-specific communities across virtually all health conditions. Rare Disease.net benefits from Health Union's infrastructure, editorial resources, and cross-community promotional opportunities.

Scale indicators2 records

Recent moves3 records

Expansion highlights4 records

Raremark competitors and assessment

Company assessment

Direct peers

  • WEGO Health: Network connecting patient leaders across conditions, including rare diseases, monetized through pharma insights and influencer programs. Operates within a category that overlaps Health Union and WEGO Health's adjacent patient-leader business.
  • MyHealthTeams: Operates condition-specific social networks for people with chronic health conditions, monetizing through pharma sponsorship and advertising. Closely matches RareDisease.net's model of free, ad-supported rare/chronic-condition communities combined with editorial content.
  • Inspire: Online patient community platform connecting patients and caregivers across thousands of conditions, with pharma and biotech sponsorship as a core revenue stream. Directly comparable in audience and monetization model to RareDisease.net.
  • Belong.life: Mobile patient community and care-management platform supporting cancer and other conditions including rare diseases, monetizing through pharma partnerships. Overlaps with RareDisease.net's patient community and sponsor-supported model.
  • PatientsLikeMe: Patient network that combines disease communities, shared health data, and patient-reported outcomes, with a heavy focus on rare conditions. Comparable as a peer community and condition-data platform serving pharma and research partners.

Emerging players

  • Orphanet: European rare disease knowledge base offering a comprehensive inventory of rare diseases and expert resources. Closely comparable to RareDisease.net's 5,000+ rare disease database, though supported publicly rather than through advertising.
  • National Organization for Rare Disorders (NORD): US rare disease umbrella nonprofit providing patient education, advocacy, and community resources. Overlaps with RareDisease.net's mission of rare-disease information and support, though operates in nonprofit model.
  • Smart Patients: Online community for patients and caregivers to share learnings about cancer and rare diseases. Directly comparable as a small, niche patient community platform with sponsor-friendly engagement.

Broad incumbents

  • Healthline Media: Major consumer health information publisher with extensive condition content. Comparable as a broad incumbent in health content and condition SEO, but does not focus on rare disease peer communities.
  • WebMD: Largest US consumer health information and advertising platform. Competes for the same pharma advertising and sponsorship dollars as RareDisease.net but covers all conditions rather than specializing in rare diseases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Raremark social profiles

Digital presence

Raremark financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Raremark leadership team

Management profile

Number of profiles

Raremark funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Raremark M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Raremark

What does Raremark do?

Raremark operates RareDisease.net, a free online health community and information platform serving rare disease patients, caregivers, and families. The platform combines a searchable database of more than 5,000 rare diseases with editorial health articles, peer community forums, patient-authored stories, and curated topic collections covering diagnosis, treatment, daily living, mental health, caregiving, and clinical trial navigation. Revenue is generated through targeted advertising and sponsored content partnerships with healthcare and pharmaceutical companies seeking access to rare disease audiences.

Is Raremark a public or private company?

Raremark is a private company. It is classified as corporate owned and is currently operating.

When was Raremark founded?

Raremark was founded in 2015. It employs 11 to 50 people.

Where is Raremark based?

Raremark is headquartered in London, United Kingdom, in the Europe region.

How does Raremark make money?

One revenue line is on record: advertising and Sponsorship.

Who are Raremark's main competitors?

Direct peers on record are WEGO Health, MyHealthTeams, Inspire, Belong.life and PatientsLikeMe. Emerging players are Orphanet, National Organization for Rare Disorders (NORD) and Smart Patients. Broad incumbents are Healthline Media and WebMD.

Does Raremark have an API?

No public API is recorded for Raremark.

What industry is Raremark in?

Raremark's product category is Online Health Community. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of HLACAHAH, Patient Registries & Chronic Disease Registry Analytics. Its NAICS code is 6241 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ClinicalresearchnewsonlineGlobal rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTORaremark appointed Dale Jessop as Chief Technical Officer, bringing two decades of healthtech experience. He previously led Exco InTouch and built an eConsent platform acquired in 2020. The company expects 2021 to be a pivotal year for growth.ClinicalresearchnewsonlineGlobal healthtech company Raremark appoints Nicki Grundy as its Chief Financial OfficerRaremark appointed Nicki Grundy as Chief Financial Officer to support its accelerated growth. Grundy brings over 20 years of experience, including roles at CrownBio, Exco InTouch, and Peppermint Technology. The appointment is part of a wider leadership move that saw Jeremy Edwards become CEO in 2020.PR NewswireRare Disease Patient Platform Raremark Partners with TriNetXTriNetX announced a partnership with Raremark, a patient data platform for rare diseases, to integrate patient demographics and diagnoses into its global health research network. This collaboration aims to expand clinical trial opportunities by allowing pharmaceutical companies to directly connect with rare disease patients through TriNetX's Trial Connect functionality.PR NewswirePatient-Data Platform Raremark Enhances Executive Team to Accelerate Progress in Rare Disease ResearchRaremark, a London-based patient-data platform focused on rare diseases, announced the appointment of three industry experts to its executive team: Neil Rotherham as Chairman, Tim Davis as CEO, and Jeremy Edwards as Chief Commercial Officer. The new leadership team brings over 100 years of combined experience in life sciences, patient engagement, and mobile technology. Raremark provides biopharmaceutical companies with anonymized patient data to accelerate clinical development, with a stated vision of treating all rare diseases.London TechWatchRaremark Raises £3M Because Suffering From a Rare Health Condition Should Not Mean Struggling to Find Information – London TechWatchRaremark raised £3M in a pre-Series A round, bringing total funding to £4.1M. The machine-learning platform aggregates data from people with rare conditions, targeting the £262B rare disease market. It plans to expand communities and build a Boston business development team.FinSMEsRaremark Raises £3m in FundingRaremark, a London-based rare disease patient-data platform, raised £3m in funding led by AlbionVC and Ananda Ventures. The company will use the funds to develop its patient-engagement and data-analysis technology for biopharmaceutical companies. It also has an office in Boston, US.Business InsiderLondon startup Raremark is helping thousands of people suffering from rare diseasesLondon startup Raremark, founded in 2015, has helped at least 2,000 people with seven rare diseases. It plans to expand to 400 disease types and has raised £680,000 in seed funding. Founder Julie Walters aims to raise a Series A round soon.